richard g. higby, ph.d. president arista laboratories, inc
TRANSCRIPT
Acceptable Analytical Methods for Assessing the Quantity of Each
ConstituentRichard G. Higby, Ph.D.
PresidentArista Laboratories, Inc.
1. Analytical methods should not be prescribed by law
2. A defined quality system is necessary3. Machine smoking conditions must be clearly
defined4. Replicate requirements need to be explicitly
stated
Key Points
ISO methods are valuable◦ Validated through collaborative studies◦ Process of development is lengthy◦ Only six methods exist today for mainstream smoke◦ Development continues through WHO’s TobLabNet, CORESTA
Published literature methods are not “optimized”◦ Administrative or technical errors exist◦ Detail is often insufficient◦ Correction conflicts with statutes
Sound principles of validation should prevail◦ Consistent with FDA’s approach in other areas◦ Accreditation and audits reinforce practices
Analytical methods should not be prescribed by law
ISO 17025 laboratory standard◦ Scheduled and periodic assessments◦ Laboratories exist today accredited to ISO 17025 for tobacco
specific work◦ Accrediting bodies are increasingly rigorous
Good Laboratory Practices ◦ Consistent with FDA’s practice in other areas◦ Limited tobacco specific capacity exists today◦ Compliant equipment will be slow to develop for the tobacco
smoke specialty equipment (smoking machines)◦ Economies of scale do not exist for instrument development
A defined quality system is necessary
Machine smoking is not representative of human smoking behavior◦ Allows product to product comparisons◦ Published methods such as ISO or the Canadian intense method
are well understood◦ The ISO method does not deliver the same results as the FTC
method which should be abandoned
Machine smoking conditions must be clearly defined
Tobacco is a natural product◦ Subject to seasonal variation◦ Variability requires a larger sample to be statistically significant
Emissions are more variable than constituents◦ Health Canada TRR prescribes 7 replicates for emissions
(smoke)◦ Health Canada TRR prescribes 3 replicates for constituents
(tobacco)◦ FTC and Massachusetts prescribed an average of 100 cigarettes
(20 replicates) for TNC which is excessive
Replicate requirements need to be explicitly stated
Time is short◦ Establishing capacity may be a challenge if notice is short◦ Implementing a quality system requires time to qualify
personnel and equipment◦ We encourage the early publication of the list of constituents
and the testing requirements
Conclusion